Aptorum Group Ltd Cl A (APM) |
|
3.3 -0.21 (-5.98%)
|
02-25 11:40 |
|
Open: |
3.51 |
Pre. Close: |
3.51 |
|
High:
|
3.52 |
Low:
|
3.21 |
|
Volume:
|
327,648 |
Market Cap:
|
112M |
|
|
|
|
Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly infectious diseases and cancers. Its pipeline through the establishment of drug discovery platforms enable the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases. The company is also pursuing therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas. It also has projects focused on surgical robotics and natural supplement for women undergoing menopause and experiencing related symptoms. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
3.832 - 3.857 |
3.857 - 3.879 |
|
Low:
|
3.424 - 3.447 |
3.447 - 3.467 |
|
Close:
|
3.476 - 3.514 |
3.514 - 3.545 |
|
Technical analysis |
as of: 2021-02-25 11:07:57 AM |
|
Overall:
|
 |
| Stoxline posted a STRONG SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 4.68  One year: 5.33 |
| Support: |
Support1: 3.11 Support2: 2.59 |
| Resistance: |
Resistance1: 4.01 Resistance2: 4.56 |
| Pivot: |
3.65 |
| Moving Average: |
MA(5): 3.69 MA(20): 3.57
MA(100): 2.78  MA(250): 3.00 |
| MACD: |
MACD(12,26): 0.14 Signal(9): 0.19 |
| Stochastic oscillator: |
%K(14,3): 19.70 %D(3): 38.70 |
| RSI: |
RSI(14): 46.21 |
| 52-week: |
High: 14.23 Low: 1.16 Change(%): -45.0 |
| Average Vol(K): |
3-Month: 70485 10-Days: 65126 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.APM has closed above bottom band by 13.6%. Bollinger Bands are 9.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Mon, 22 Feb 2021
Is Aptorum Group Ltd (APM) a Good Choice in Biotechnology Monday? - InvestorsObserver
Thu, 18 Feb 2021
Is Aptorum Group Ltd (APM) a Stock to Watch This Week? - InvestorsObserver
Thu, 18 Feb 2021
Dogecoin Hits New All Time-High As Elon Musk Takes Twitter Frenzy To A New Level - Benzinga
Thu, 21 Jan 2021
Is Aptorum Group Ltd (APM) the Top Pick in the Biotechnology Industry? - InvestorsObserver
Thu, 10 Dec 2020
Aptorum Group Ltd (APM) Stock: Is It a Good Pick? - InvestorsObserver
Fri, 02 Oct 2020
Aptorum Group Announces Closing of $9.0 Million Public Offering - Business Wire
|
Financial Analysis |
| Growth |
n/a |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Underperform |
Price to Earnings: |
Underperform |
| Return on Equity: |
Underperform |
Debt to Equity: |
Neutral |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
12 |
| Shares Float (M) |
7 |
|
% Held by Insiders
|
26.43 |
|
% Held by Institutions
|
0.77 |
|
Shares Short (K)
|
43 |
|
Shares Short P. Month (K)
|
77 |
Stock Financials |
|
EPS
|
-0.536 |
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
0.650 |
|
Profit Margin
|
|
|
Operating Margin
|
-2935.77 |
|
Return on Assets (ttm)
|
-47.5 |
|
Return on Equity (ttm)
|
-84.1 |
|
Qtrly Rev. Growth
|
36.5 |
|
Gross Profit (p.s.)
|
-0.022 |
|
Sales Per Share
|
0.054 |
|
EBITDA (p.s.)
|
-1.457 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-13 |
|
Levered Free Cash Flow (M)
|
-7 |
Stock Valuations |
|
PE Ratio
|
-6.16 |
|
PEG Ratio
|
|
|
Price to Book value
|
5.08 |
|
Price to Sales
|
61.32 |
|
Price to Cash Flow
|
-2.92 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
